
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sm D3 CRISPR/Cas9 KO Plasmid (h) | sc-405302 | 20 µg | $397.00 |
SNRPD3 encodes the Sm D3 core protein, a conserved component of the Sm ring that assembles onto snRNAs to form spliceosomal small nuclear ribonucleoproteins (snRNPs). Sm D3 supports snRNP biogenesis and pre-mRNA splicing fidelity, linking it to spliceosome assembly dynamics and RNA processing quality control. Perturbation of Sm core proteins can shift transcript isoform usage and affect gene expression programs governing cell cycle progression, stress responses, and differentiation. Because aberrant splicing is a common feature of many disease states, SNRPD3 is frequently studied as a node connecting spliceosomal integrity to genome-wide RNA maturation phenotypes in human cells.
Sm D3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SNRPD3 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SNRPD3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SNRPD3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sm D3 protein expression.
This CRISPR knockout system enables efficient generation of SNRPD3-deficient cell models for investigation of Sm D3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.